ASH-话题@MedSci

#ASH#

242篇内容 | 3332人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301163, encodeId=5c49130116382, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, objectType=article, longId=60416, objectId=efc1604161b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc1604161b, replyNumber=0, likeNumber=122, createdTime=2015-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc1604161b, moduleTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efc1604161b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301160, encodeId=cf971301160f4, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：疫苗接种新策略可降低癌症患者流感风险, objectType=article, longId=60389, objectId=72df60389d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72df60389d3, replyNumber=0, likeNumber=91, createdTime=2015-12-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72df60389d3, moduleTitle=ASH 2015：疫苗接种新策略可降低癌症患者流感风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72df60389d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301159, encodeId=a40f1301159fb, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：癌症相关血栓患者使用华法林也是安全的, objectType=article, longId=60335, objectId=f1dc603355d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1dc603355d, replyNumber=0, likeNumber=67, createdTime=2015-12-08, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1dc603355d, moduleTitle=ASH 2015：癌症相关血栓患者使用华法林也是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1dc603355d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301158, encodeId=832c13011585c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASHG 2015：从基因层面解读戒烟戒酒与衰老, objectType=article, longId=57187, objectId=90ea5e1876e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ea5e1876e, replyNumber=0, likeNumber=88, createdTime=2015-10-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ea5e1876e, moduleTitle=ASHG 2015：从基因层面解读戒烟戒酒与衰老, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90ea5e1876e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301157, encodeId=2ae6130115e43, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=2015 JSGE NAFLD/NASH循证临床实践指南解读, objectType=article, longId=52115, objectId=f1ba521150c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ba521150c, replyNumber=0, likeNumber=78, createdTime=2015-06-17, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ba521150c, moduleTitle=2015 JSGE NAFLD/NASH循证临床实践指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ba521150c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301156, encodeId=5e991301156f6, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JOH：应用他汀类药物治疗可预防NASH, objectType=article, longId=51543, objectId=055d5154317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=055d5154317, replyNumber=0, likeNumber=74, createdTime=2015-06-04, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=055d5154317, moduleTitle=JOH：应用他汀类药物治疗可预防NASH, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=055d5154317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301155, encodeId=3c5c1301155a3, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=吉利德科学4.7亿美元收购Phenex，进入非酒精脂肪肝（NASH）, objectType=article, longId=45184, objectId=daa3451842d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daa3451842d, replyNumber=0, likeNumber=88, createdTime=2015-01-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daa3451842d, moduleTitle=吉利德科学4.7亿美元收购Phenex，进入非酒精脂肪肝（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daa3451842d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301154, encodeId=ebfb1301154bd, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014亮点：黄晓军研究团队闪耀美国血液学年会, objectType=article, longId=44462, objectId=e2fe44462b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2fe44462b3, replyNumber=0, likeNumber=73, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2fe44462b3, moduleTitle=ASH 2014亮点：黄晓军研究团队闪耀美国血液学年会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2fe44462b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301131, encodeId=c024130113157, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存, objectType=article, longId=44366, objectId=115544366e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115544366e4, replyNumber=0, likeNumber=62, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115544366e4, moduleTitle=ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=115544366e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301132, encodeId=cd58130113296, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：PD-1治疗复发性经典霍奇金淋巴瘤缓解率达66%, objectType=article, longId=44367, objectId=d1a44436eb1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1a44436eb1, replyNumber=0, likeNumber=91, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1a44436eb1, moduleTitle=ASH 2014：PD-1治疗复发性经典霍奇金淋巴瘤缓解率达66%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1a44436eb1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301133, encodeId=d55b13011339b, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：PD-1在血液肿瘤领域展现巨大潜力, objectType=article, longId=44368, objectId=16134436817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16134436817, replyNumber=0, likeNumber=71, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16134436817, moduleTitle=ASH 2014：PD-1在血液肿瘤领域展现巨大潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16134436817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301134, encodeId=b141130113464, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：Blincyto治疗ALL有效, objectType=article, longId=44369, objectId=e6c744369e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6c744369e3, replyNumber=0, likeNumber=58, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6c744369e3, moduleTitle=ASH 2014：Blincyto治疗ALL有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6c744369e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301135, encodeId=1515130113514, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：venetoclax治疗AML的II期研究数据公布, objectType=article, longId=44370, objectId=4a7c443e0bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7c443e0bd, replyNumber=0, likeNumber=0, createdTime=2014-12-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7c443e0bd, moduleTitle=ASH 2014：venetoclax治疗AML的II期研究数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7c443e0bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301136, encodeId=1f8a130113638, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：ixazomib单药维持可扩大多发性骨髓瘤缓解深度, objectType=article, longId=44371, objectId=05e8443e1ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05e8443e1ea, replyNumber=0, likeNumber=78, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05e8443e1ea, moduleTitle=ASH 2014：ixazomib单药维持可扩大多发性骨髓瘤缓解深度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05e8443e1ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301137, encodeId=ab4e130113e95, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：低剂量白细胞介素-2预防慢性移植物抗宿主病, objectType=article, longId=44373, objectId=ead7443e30b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead7443e30b, replyNumber=0, likeNumber=76, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead7443e30b, moduleTitle=ASH 2014：低剂量白细胞介素-2预防慢性移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead7443e30b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301138, encodeId=9d3b1301138dd, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：危险分层指导的aGVHD防治相关研究, objectType=article, longId=44374, objectId=7ab0443e41b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ab0443e41b, replyNumber=0, likeNumber=60, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ab0443e41b, moduleTitle=ASH 2014：危险分层指导的aGVHD防治相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ab0443e41b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301139, encodeId=e6441301139a4, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Kanti Rai获ASH的**奖项——Wallace H. Coulter奖, objectType=article, longId=44383, objectId=c5004438370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5004438370, replyNumber=0, likeNumber=73, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5004438370, moduleTitle=Kanti Rai获ASH的**奖项——Wallace H. Coulter奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5004438370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301140, encodeId=72981301140f4, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解, objectType=article, longId=44384, objectId=3eee44384ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eee44384ee, replyNumber=0, likeNumber=95, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eee44384ee, moduleTitle=ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eee44384ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301141, encodeId=d5a11301141e7, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：为T-ALL患儿带来希望的新研究, objectType=article, longId=44385, objectId=a60e443852b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60e443852b, replyNumber=0, likeNumber=67, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60e443852b, moduleTitle=ASH 2014：为T-ALL患儿带来希望的新研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a60e443852b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301142, encodeId=cf7a130114256, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：idelalisib治疗CLL和iNHL疗效初显, objectType=article, longId=44387, objectId=63784438e45, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63784438e45, replyNumber=0, likeNumber=67, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63784438e45, moduleTitle=ASH 2014：idelalisib治疗CLL和iNHL疗效初显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63784438e45)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASH

2020-05-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗

2015-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：疫苗接种新策略可降低癌症患者流感风险

2015-12-09

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：癌症相关血栓患者使用华法林也是安全的

2015-12-08

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASHG 2015：从基因层面解读戒烟戒酒与衰老

2015-10-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

2015 JSGE NAFLD/NASH循证临床实践指南解读

2015-06-17

kksonne (审核中...)

前往app查看评论内容

#ASH#

JOH：应用他汀类药物治疗可预防NASH

2015-06-04

kksonne (审核中...)

前往app查看评论内容

#ASH#

吉利德科学4.7亿美元收购Phenex，进入非酒精脂肪肝（NASH）

2015-01-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014亮点：黄晓军研究团队闪耀美国血液学年会

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：PD-1治疗复发性经典霍奇金淋巴瘤缓解率达66%

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：PD-1在血液肿瘤领域展现巨大潜力

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：Blincyto治疗ALL有效

2014-12-24

zhaojie88 (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：venetoclax治疗AML的II期研究数据公布

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：ixazomib单药维持可扩大多发性骨髓瘤缓解深度

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：低剂量白细胞介素-2预防慢性移植物抗宿主病

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：危险分层指导的aGVHD防治相关研究

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

Kanti Rai获ASH的**奖项——Wallace H. Coulter奖

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：为T-ALL患儿带来希望的新研究

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：idelalisib治疗CLL和iNHL疗效初显

2014-12-24

科室
- - 订阅+
  - 更多科室
工具
服务